4//SEC Filing
Louis Chrystal 4
Accession 0000950170-24-052872
CIK 0001783328other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:05 PM ET
Size
5.4 KB
Accession
0000950170-24-052872
Insider Transaction Report
Form 4
Louis Chrystal
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-05-01+380,000→ 380,000 totalExercise: $8.62Exp: 2034-04-30→ Voting Common Stock (380,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of April 22, 2024, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.
Documents
Issuer
TScan Therapeutics, Inc.
CIK 0001783328
Entity typeother
Related Parties
1- filerCIK 0002018696
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 4:05 PM ET
- Size
- 5.4 KB